Shillong Herald

Leber’s Hereditary Optic Neuropathy (LHON) Market Insights, Epidemiology, and Market Forecast-2030

 Breaking News
  • No posts were found

Leber’s Hereditary Optic Neuropathy (LHON) Market Insights, Epidemiology, and Market Forecast-2030

September 04
19:21 2020
Leber's Hereditary Optic Neuropathy (LHON) Market Insights, Epidemiology, and Market Forecast-2030

(Albany, US) DelveInsight has launched a new report on Leber’s Hereditary Optic Neuropathy Market

 

DelveInsight’s “Leber’s Hereditary Optic Neuropathy (LHON) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Leber’s Hereditary Optic Neuropathy (LHON) , historical and forecasted epidemiology as well as the Leber’s Hereditary Optic Neuropathy (LHON) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Leber’s Hereditary Optic Neuropathy (LHON) market report provides current treatment practices, emerging drugs, Leber’s Hereditary Optic Neuropathy (LHON) market share of the individual therapies, current and forecasted Leber’s Hereditary Optic Neuropathy (LHON) market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Leber’s Hereditary Optic Neuropathy (LHON) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

 

Leber’s hereditary optic neuropathy (LHON) is a distinct type of “inherited optic atrophies” or “hereditary optic neuropathies.” It refers to an optic nerve dysfunction due to point mutations in the mitochondrial DNA and is transmitted in non-mendelian pattern. The primary cell type lost in LHON is the retinal ganglion cell, which is highly susceptible to disrupted ATP production and oxidative stress. Inheritance of LHON follows the mitochondrial genetics, and it has a highly variable clinical phenotype, as other genetic and environmental factors also play a role. It is characterized by bilateral subacute loss of central vision due to focal degeneration of the retinal ganglion cell layer and optic nerve. LHON most commonly presents as painless loss of central vision in one eye, followed rapidly by loss of vision in the other eye within a few months. In some cases, both eyes will be affected from the onset. It can have both ophthalmologic and extra-ocular features. Ophthalmologic manifestations can further be subdivided into the acute phase and chronic phase.

 

View Free Sample Page:- https://www.delveinsight.com/sample-request/lebers-hereditary-optic-neuropathy-lhon-market

 

Leber’s Hereditary Optic Neuropathy Treatment

The mainstay of clinical treatment for Leber’s hereditary optic neuropathy (LHON) remains supportive rather than curative. The management of LHON patients includes low vision aids, occupational rehabilitation, and registration with local social services. Those with mitochondrial mutations should be advised to refrain from smoking and binge alcohol drinking. Furthermore, screening for extraocular manifestations should be carried out in the form of an electrocardiogram and complete neurological evaluation. Nutritional supplements: combinations of vitamins (e.g., B2, B3, B12, C, E, and folic acid) and other supplements such as alpha-lipoic acid, carnitine, creatine, L-arginine, and dichloroacetate have been tried to treat mitochondrial disorders, including LHON. However, analyses have shown little proof of efficacy with these interventions.

 

Leber’s Hereditary Optic Neuropathy Market

The treatment of mitochondrial disorders is still in its infancy, even though there is promising research underway. LHON contributes significantly to the burden of blindness amongst young adolescents. Therefore, it becomes essential to evaluate and correctly identify the underlying genetic make-up.

Identification and mapping of the genes will help in preventing transmission to the offspring from the affected maternal carries. It will not only help in a better understanding of the disease but also help in exploring and evaluating different treatment modalities. In addition, the newly emerging treatment modalities, such as gene therapy, stem cells, and others, are likely to be a ray of hope for the individuals with these mutations; however, long term studies are needed to evaluate their role in terms of efficacy, benefits and adverse effects.

 

Leber’s Hereditary Optic Neuropathy Report Scope

  • The report covers the descriptive overview of Leber’s Hereditary Optic Neuropathy (LHON) , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Leber’s Hereditary Optic Neuropathy (LHON) epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Leber’s Hereditary Optic Neuropathy (LHON) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Leber’s Hereditary Optic Neuropathy (LHON) market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Leber’s Hereditary Optic Neuropathy (LHON) market

 

Download Free Sample Page:- https://www.delveinsight.com/sample-request/lebers-hereditary-optic-neuropathy-lhon-market

 

Table of content

1. Key Insights

2. Executive Summary of Leber’s Hereditary Optic Neuropathy (LHON)

3. Competitive Intelligence Analysis for Leber’s Hereditary Optic Neuropathy (LHON)

4. Leber’s Hereditary Optic Neuropathy (LHON) : Market Overview at a Glance

5. Leber’s Hereditary Optic Neuropathy (LHON) : Disease Background and Overview

6. Patient Journey

7. Leber’s Hereditary Optic Neuropathy (LHON) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Leber’s Hereditary Optic Neuropathy (LHON) Treatment

11. Marketed Products

12. Emerging Therapies

13. Leber’s Hereditary Optic Neuropathy (LHON) : Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Leber’s Hereditary Optic Neuropathy (LHON)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Why should you buy this report?

 

  • The report will help in developing business strategies by understanding trends shaping and driving the Leber’s Hereditary Optic Neuropathy (LHON) market
  • To understand the future market competition in the Leber’s Hereditary Optic Neuropathy (LHON) market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Leber’s Hereditary Optic Neuropathy (LHON) in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Leber’s Hereditary Optic Neuropathy (LHON) market
  • To understand the future market competition in the Leber’s Hereditary Optic Neuropathy (LHON) market

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Related Articles